What we look for
Management
We back talented and committed management teams who share the same ambition to grow shareholder value as we do.
Funding requirement
We can support transactions requiring capital from £100,000 via our specialist regional funds, up to £20 million from our MBO Fund.
.png?width=447&height=448&name=graph%20(1).png)
Stage of growth
We back entrepreneurial and innovative smaller companies with revenues of at least £1 million per annum, which are growing quickly.
Location
We prefer to invest in UK domiciled businesses.
Sector
We are sector agnostic, supporting ambitious businesses across a range of the UK's most vibrant industries.
Future potential
We don't always expect businesses to be the finished article. We aim to add value in companies which have a clear, credible business strategy, capable of delivering growth in profit and earnings.
Our growth funding options
Growth Capital
Looking to scale up, expand into new markets, or launch a new product? We can help you achieve that goal. The Maven VCTs are active investors in high growth companies typically less than 10 years old, and can invest from £1 million to £6 million in a single transaction.
Private Equity
Looking to buy the business you run, sell part of your business, or pursue a buy and build strategy? Private Equity can be used to finance a wide range of transaction types and help an incumbent management team to acquire a stake in the business they manage.
Our Regional Funds
We manage a range of specialist funds that provide flexible debt or equity finance solutions for dynamic and growth focused small and medium-sized enterprises (SMEs) across the Midlands and the North of England.
Recent growth investments
£6.5 million
Transaction size
There is a vast amount of invaluable evidence, which is hard to access and is subsequently unused by companies working on new therapeutics. Our mission at Biorelate is to capture this untapped data and help them make sense of it. With this improved understanding we are empowering these companies to make better decisions and speed up the drug discovery process.
Dr Daniel Jamieson, founder and CEO of BioRelate
£5 million
Transaction size
This funding will enable us to build out our sales and marketing capabilities and accelerate expansion with a presence in the US which is a huge potential market for us. We will also continue scaling what we have already built with further product development and innovation – we have a clearly defined target market and products with the functionality to meet a very real business need.
Tom Dunlop, Co-founder and CEO at Summize
£2.5 million
Transaction size
Since our inception we have had backing from a number of small-medium sized investors, but this is the largest external investment we have ever had. Fundraising to this scale will have a significant impact on what we do next, enabling us to expand into new territories, support more organisations to make a real difference and invest heavily in our technology platform to ensure we’re always at the forefront of what we do.
Tony Wines, Turnkey CEO and Founder of Turnkey
£2.85 million
Transaction size
We are thrilled to announce this additional funding for Plyable and to be partnering with a highly experienced investment firm such as Maven as we start our next chapter of growth. We are excited to deploy the capital to the company’s ongoing technological development and expansion of our ecosystem, particularly in Europe and North America.
Martin Oughton, CEO at Plyable
£3 million
Transaction size
We are incredibly excited to partner with Maven alongside our founder investors, to continue the company’s rapid growth. These funds will be used to grow the business at scale with significant product enhancements. This will ensure we continue to be the leading end-to-end apprenticeship training platform while extending into other areas of training provision for our existing and new clients.
John Ingram, CEO at Bud
£5.9 million
Transaction size
XR Games has achieved some great milestones in a short space of time, and we are delighted to support the business at such an exciting stage in its growth journey. Immersive technology has huge potential and the team’s experience, ambition and delivery has been instrumental in XR developing such an impressive list of global clients and partners.
Gavin Bell, Investment Director at Maven
£1.45 million
Transaction size
The Company is led by a very capable team, and they have made good commercial progress to date. Growth is backed up by strong recurring revenues and a strong pipeline of prospective new clients. We are delighted to have structured a solution which will support the delivery of management’s ambitious targets.
Melanie Goward, Partner at Maven
£4 million
Transaction size
We can see the significant value that its tech solution offers to clients. Its advisory and consultancy services are already highly rated and trusted by its client base and the Maven investment will provide the resource Novatus needs to continue to provide its high level of service while pursuing sales growth, alongside the continued development of its complementary technology platform.
Alan Robertson, Partner at Maven
Meet our investment team
Our experienced team of professionals based across the country come from a variety of commercial, financial, and industry backgrounds, and have completed hundreds of investments in ambitious British businesses. Whatever your sector, stage of growth, or geography we have the necessary expertise.
.jpg)
.png)
